A new 16-week study of 204 adult epilepsy patients found that 98% of participants believe that all patients with epilepsy should have a seizure action plan (SAP), regardless of seizure status. These ...

Pharmacotherapeutic issues associated with generic substitutions of antiseizure medications (ASM) may not only be the result of the Food and Drug Administration’s (FDA) approved bioequivalence ...

Like many teenagers, Danielle Holton's first car was a ticket to freedom. At age 17, she bought a used Hyundai wagon from her mom, paying for it with money from her job as a certified nursing ...

Seizure control may take time—often a year or more—but most patients achieve it, bringing new hope for life with epilepsy. For millions of people living with ...

People with psychogenic nonepileptic seizures (PNES) who were treated with cognitive behavioral therapy over a longer period of time than expected had improved seizure control and psychiatric symptoms ...

Developed under the guidance of epilepsy, neurology, pharmacy, and specialty nurse advisors, these patient support apps, now available in the Mobile Health Library (MHL) system, have been designed to ...

Patients with epilepsy may report less than half of their seizures to clinicians, according to survey results presented online as part of the 2020 American Academy of Neurology Science Highlights.

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

The first seizure clinic model enabled rapid diagnosis and treatment for children with epilepsy, according to data presented ...